<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000641131"><TermName>HGS-ETR1</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the surface of some tumor cells.  This may kill the tumor cells. HGS-ETR1 is a type of monoclonal antibody. Also called anti-TRAIL R1-mAb and mapatumumab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>HGS-ETR1</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer. Se une a una proteína de la superficie de algunas células tumorales que se llama TRAIL R1. Podría destruir células tumorales. HGS-ETR1 es un tipo de anticuerpo monoclonal. También se llama anti-TRAIL R1-mAbmAb anti TRAIL R1 y mapatumumab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-05-19</DateFirstPublished></GlossaryTerm>
